Idactamab

[1]Pore N, et al. Discovery and development of MEDI7247, a novel pyrrolobenzodiazepine (PBD) -based antibody drug conjugate targeting ASCT2, for treating hematological cancers[J]. Blood, 2018, 132: 4071.|[2]Monks N R, et al. Abstract LB-295: MEDI7247, a novel pyrrolobenzodiazepine ADC targeting ASCT2 with potent in vivo activity across a spectrum of hematological malignancies[J]. Cancer Research, 2018, 78 (13_Supplement) : LB-295-LB-295.